Before the opening bell, Immune Therapeutics, Inc. (OTCQB: IMUN) announced the appointment of two new members to its board of directors: Dr. Clifford A. Selsky and Paul Akin. Akin brings a wealth of financial experience developed across his prior operating and board roles to the Immune Therapeutics board, while Selsky offers a critical perspective as […]
The Stocks To Buy Now Blog
Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.